EMD Serono
About EMD Serono
EMD Serono is a specialty innovator that helps create, improve and prolong lives for people living with infertility, multiple sclerosis and cancer. It is the healthcare business of Merck KGaA, Darmstadt, Germany, and operates in the United States.
Recent News
Pharma and Biotech Layoffs 2026 Watch
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer
What Does 17 Pharma MFN Deals Are Underneath the Press Releases: The Real Primary Source Stack, the GLP1 Numbers, TrumpRX Plumbing, and Where the New Adjudication Layer Gets Monetized
MFN Drug Pricing Proposal Raises Questions Around Access, Innovation, and Commercial Coverage
Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations
White House’s Online Service for Drug Sales Debuts with Limited Impact on Prices
Recent Deals
No recent deals for this company.